Page last updated: 2024-08-25

chitosan and rifampin

chitosan has been researched along with rifampin in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (18.18)	29.6817
2010's	22 (50.00)	24.3611
2020's	14 (31.82)	2.80

Authors

Authors	Studies
Murthy, KV; Rao, BS	1
Anandan, R; Mathew, PT; Santhosh, S; Sini, TK	2
Antimisiaris, SG; Dracopoulos, V; Fadda, AM; Manca, ML; Mourtas, S	1
Alves, JP; Arguelho, ML; Garcia, CA; Romão, LC; Santos, NG; Santos, RH	1
Cao, Z; Sun, Y	1
Antimisiaris, SG; Fadda, AM; Loy, G; Manca, ML; Zaru, M	1
Antimisiaris, SG; Fadda, AM; Manca, ML; Zaru, M	1
Fadda, AM; Lai, F; Loy, G; Manca, ML; Manconi, M; Matricardi, P; Valenti, D	1
Feng, Y; Gao, Y; Li, B; Li, X; Zhou, Y	1
Deng, Y; Luo, J; Lv, W; Sun, Y	1
Chen, XN; Gu, YX; Lee, JH; Lee, WY; Wang, HJ	1
Raj, V; Rajan, M	1
Chaubey, P; Mishra, B	1
Fávere, V; Lacerda, L; Laranjeira, MC; Parize, AL; Stulzer, HK	1
Fadda, AM; Manca, ML; Manconi, M; Nacher, A; Sales, OD; Valenti, D	1
Garg, T; Goyal, AK; Rath, G	1
Bannalikar, AS; Jain, RR; Menon, MD; Pai, RV	1
Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Rath, G	2
Butani, S; Parmar, R; Rawal, T; Tyagi, RK	1
Chan, LW; Shah, K; Wong, TW	1
Chaves, LL; Ferreira, D; Lima, SC; Pinheiro, M; Pinheiro, S; Pinto, S; Reis, S; Sarmento, B; Vieira, ACC	1
Annaraj, J; Ayyanaar, S; Dhaveethu Raja, J; Kesavan, MP; Rajesh, J; Sakthipandi, K; Vijayakumar, V	1
Chavhan, S; Kunda, N; Petkar, KC; Saleem, I; Sawant, KK; Somavarapu, S; Taylor, KMG	1
Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Smeltzer, MS; Wells, CM	1
Cai, X; Chen, T; Guo, L; Liao, W; Ma, D; Tan, W; Wang, W; Wu, T; Xiang, W; Yu, W; Zhang, J; Zhou, J	1
Alarfaj, AA; Amarnath Praphakar, R; Munusamy, MA; Rajan, M; Suresh Kumar, S; Yuan, X	1
Granero, GE; Páez, PL; Sánchez-Borzone, ME; Scolari, IR	1
Abdul Hamid, ZA; Khan, A; Md Akil, H; Md Rasib, SZ	1
Alcouffe, P; Ladavière, C; Montembault, A; Peers, S	1
Batool, S; Dar, MJ; Din, FU; Khaleeq, N; Khan, GM; Kim, DW; Rabia, S	1
Granero, GE; Musri, MM; Páez, PL; Petiti, JP; Scolari, IR; Torres, A	1
Croft, SL; Loiseau, PM; Pomel, S	1
Chaves, LL; Ferreira, D; Lima, SC; Neto, PJR; Pinheiro, M; Reis, S; Sarmento, B; Vieira, ACC	1
Capáková, Z; Ngwabebhoh, FA; Patwa, R; Saha, N; Saha, P; Zandraa, O	1
Fanani, ML; Granero, GE; La Cruz-Thea, B; Musri, MM; Natali, L; Scolari, IR; Volpini, X	1
Arumugam, SK; Doble, M; Mitra, K; Ravindran, R	1
Chaubey, P; Fernandes, T; Kaur, P; Narayanan, S; Prabhu, P; Sawarkar, SP; Vk, R	1
Barroso, N; Lanceros-Mendez, S; Maiz-Fernández, S; Pérez-Álvarez, L; Silván, U; Vilas-Vilela, JL	1
Cui, X; Hao, Y; Li, G; Li, L; Li, Y; Ma, Y; Sha, X; Tang, PF; Wang, H; Wang, L; Zhang, K; Zhang, Z; Zhou, J	1
Boni, FI; Chorilli, M; Gremião, MPD; Turco, BO	1
Abruzzo, A; Bigucci, F; Cerchiara, T; Corazza, E; Croatti, V; Luppi, B; Pasquale Nicoletta, F; Sallustio, V; Vitali, B; Zuccheri, G	1
Ammendolia, MG; Bordi, F; Carafa, M; Fabiano, MG; Forte, J; Fraziano, M; Hanieh, PN; Marianecci, C; Olimpieri, T; Poerio, N; Rinaldi, F; Sennato, S	1

Reviews

2 review(s) available for chitosan and rifampin

Article	Year
Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin. Materials science & engineering. C, Materials for biological applications, 2014, Jun-01, Volume: 39 Topics: Alginates; Antibiotics, Antitubercular; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Rifampin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction	2014
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis. Molecules (Basel, Switzerland), 2020, Sep-09, Volume: 25, Issue:18 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid	2020

Article

Year

Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin.

Materials science & engineering. C, Materials for biological applications, 2014, Jun-01, Volume: 39

Topics: Alginates; Antibiotics, Antitubercular; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Rifampin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2014

Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.

Molecules (Basel, Switzerland), 2020, Sep-09, Volume: 25, Issue:18

Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid

2020

Other Studies

42 other study(ies) available for chitosan and rifampin

Article	Year
Preparation and in vitro evaluation of chitosan matrices cross-linked by formaldehyde vapors. Drug development and industrial pharmacy, 2000, Volume: 26, Issue:10 Topics: Antibiotics, Antitubercular; Biocompatible Materials; Chitin; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Fixatives; Formaldehyde; Kinetics; Rifampin; Volatilization	2000
Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology, 2006, Feb-15, Volume: 219, Issue:1-3 Topics: Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Cholesterol; Fatty Acids, Nonesterified; Isoniazid; Lipid Peroxidation; Lipid Peroxides; Liver; Liver Function Tests; Male; Rats; Rats, Wistar; Rifampin; Triglycerides	2006
Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. European journal of pharmacology, 2007, Oct-15, Volume: 572, Issue:1 Topics: Analysis of Variance; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chitosan; Isoniazid; Lipid Peroxidation; Liver; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Rifampin	2007
PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids and surfaces. B, Biointerfaces, 2008, Apr-01, Volume: 62, Issue:2 Topics: Adhesiveness; Administration, Inhalation; Antibiotics, Antitubercular; Cell Line; Chemical Phenomena; Chemistry, Physical; Chitosan; Diffusion; Drug Compounding; Drug Delivery Systems; Drug Stability; Electrochemistry; Emulsions; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Mucins; Mucous Membrane; Nebulizers and Vaporizers; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pulmonary Alveoli; Rifampin; Solvents; Tetrazolium Salts; Thiazoles	2008
Evaluation of the physico-chemical properties of chitosan as a potential carrier for rifampicin, using voltammetric and spectrophotometric techniques. Bioelectrochemistry (Amsterdam, Netherlands), 2008, Volume: 72, Issue:2 Topics: Carbon; Chitosan; Electrochemistry; Electrodes; Hydroquinones; Molecular Structure; Oxidation-Reduction; Rifampin; Spectrum Analysis	2008
Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems. Journal of biomedical materials research. Part A, 2009, Jun-15, Volume: 89, Issue:4 Topics: Anti-Infective Agents; Biofilms; Chitosan; Drug Delivery Systems; Microbial Sensitivity Tests; Rifampin; Solutions; Solvents; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors	2009
Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Colloids and surfaces. B, Biointerfaces, 2008, Dec-01, Volume: 67, Issue:2 Topics: Chitosan; Drug Carriers; Drug Delivery Systems; Drug Stability; Kinetics; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin	2008
Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloids and surfaces. B, Biointerfaces, 2009, Jun-01, Volume: 71, Issue:1 Topics: Administration, Inhalation; Cell Line; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Lung; Rifampin	2009
Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin. Journal of pharmaceutical sciences, 2012, Volume: 101, Issue:2 Topics: Chitosan; Drug Carriers; Liposomes; Lung; Particle Size; Polysaccharides, Bacterial; Rheology; Rifampin	2012
Chitosan hydrogels with 3D Liesegang ring structure for rifampicin release. Journal of controlled release : official journal of the Controlled Release Society, 2011, Nov-30, Volume: 152 Suppl 1 Topics: Chemistry, Pharmaceutical; Chitosan; Diffusion; Drug Carriers; Drug Compounding; Hydrogels; Kinetics; Microscopy, Electron, Scanning; Molecular Structure; Rifampin; Sodium Hydroxide; Solubility; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical	2011
Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery. Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:2 Topics: Animals; Anti-Infective Agents; Bacteria; Biocompatible Materials; Biofilms; Cell Survival; Chitosan; Ciprofloxacin; Drug Delivery Systems; Fibroblasts; Membranes, Artificial; Microbial Sensitivity Tests; Ozone; Polyurethanes; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties; Time Factors	2013
Multifunctional surfaces with biomimetic nanofibres and drug-eluting micro-patterns for infection control and bone tissue formation. European cells & materials, 2012, Sep-24, Volume: 24 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial Infections; Biofilms; Biomimetic Materials; Cell Differentiation; Cells, Cultured; Chitosan; Mice; Nanofibers; Osteoblasts; Osteogenesis; Polyesters; Rifampin; Staphylococcus epidermidis	2012
Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery. Carbohydrate polymers, 2013, Oct-15, Volume: 98, Issue:1 Topics: Chitosan; Delayed-Action Preparations; Drug Carriers; Gelatin; Lactic Acid; Mycobacterium smegmatis; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rifampin; Solvents; Volatilization	2013
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydrate polymers, 2014, Jan-30, Volume: 101 Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin	2014
Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin. International journal of pharmaceutics, 2014, Sep-10, Volume: 472, Issue:1-2 Topics: Administration, Inhalation; Antibiotics, Antitubercular; Calorimetry, Differential Scanning; Carrageenan; Cell Line, Tumor; Cell Survival; Chitosan; Drug Compounding; Humans; Liposomes; Particle Size; Rifampin; X-Ray Diffraction	2014
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis. Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:3 Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Chitosan; Disease Models, Animal; Drug Carriers; Female; Humans; Isoniazid; Mice; Mice, Inbred BALB C; Nanoparticles; Rifampin; Tuberculosis, Pulmonary	2016
Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin. Journal of aerosol medicine and pulmonary drug delivery, 2016, Volume: 29, Issue:2 Topics: Administration, Inhalation; Aerosols; Animals; Antibiotics, Antitubercular; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Dry Powder Inhalers; Female; Humans; Kinetics; Lactose; Lung; Macrophages; Particle Size; Powders; Rats, Sprague-Dawley; Rifabutin; Rifampin; Solubility; Surface Properties; U937 Cells	2016
Development and Characterization of Nanoembedded Microparticles for Pulmonary Delivery of Antitubercular Drugs against Experimental Tuberculosis. Molecular pharmaceutics, 2015, Nov-02, Volume: 12, Issue:11 Topics: Animals; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Galactans; Macrophages; Mannans; Mice; Mice, Inbred BALB C; Mycobacterium; Nanocapsules; Plant Gums; Rifampin; Tuberculosis, Pulmonary	2015
Chemotherapeutic Evaluation of Guar Gum Coated Chitosan Nanoparticle Against Experimental Tuberculosis. Journal of biomedical nanotechnology, 2016, Volume: 12, Issue:3 Topics: Animals; Antitubercular Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Female; Galactans; Isoniazid; Mannans; Mice; Mice, Inbred BALB C; Nanocapsules; Plant Gums; Rifampin; Treatment Outcome; Tuberculosis	2016
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis. Colloids and surfaces. B, Biointerfaces, 2017, Jun-01, Volume: 154 Topics: Administration, Inhalation; Animals; Antitubercular Agents; Cell Line; Chitosan; Delayed-Action Preparations; Drug Liberation; Dry Powder Inhalers; Freeze Drying; Half-Life; Lung; Macrophages, Alveolar; Male; Mice; Nanoparticles; Particle Size; Powders; Rats; Rats, Wistar; Rifampin; Tuberculosis, Pulmonary	2017
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment. Drug delivery, 2017, Volume: 24, Issue:1 Topics: Administration, Inhalation; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Chitosan; Drug Liberation; Emulsions; Macrophages; Nanoparticles; Oleic Acid; Particle Size; Rifampin; Tuberculosis; Viscosity	2017
Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis. International journal of pharmaceutics, 2018, Jan-30, Volume: 536, Issue:1 Topics: Antitubercular Agents; Chitosan; Drug Carriers; Drug Liberation; Excipients; Lipids; Nanoparticles; Nanostructures; Particle Size; Rifampin; Tuberculosis	2018
Magnetic iron oxide nanoparticles (MIONs) cross-linked natural polymer-based hybrid gel beads: Controlled nano anti-TB drug delivery application. Journal of biomedical materials research. Part A, 2018, Volume: 106, Issue:4 Topics: Antitubercular Agents; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Gels; Kinetics; Magnetite Nanoparticles; Microspheres; Polyethylene Glycols; Polymers; Rifampin; Spectrophotometry, Ultraviolet; Thermogravimetry; Time Factors; Water; X-Ray Diffraction	2018
Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design. AAPS PharmSciTech, 2018, Volume: 19, Issue:4 Topics: A549 Cells; Antibiotics, Antitubercular; Cell Proliferation; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrophobic and Hydrophilic Interactions; Lung; Nanoparticles; Particle Size; Rifampin	2018
Ciprofloxacin and Rifampin Dual Antibiotic-Loaded Biopolymer Chitosan Sponge for Bacterial Inhibition. Military medicine, 2018, 03-01, Volume: 183, Issue:suppl_1 Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Bacterial Infections; Biopolymers; Chitosan; Chromatography, High Pressure Liquid; Ciprofloxacin; Mice; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus	2018
Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin. Carbohydrate polymers, 2018, Oct-01, Volume: 197 Topics: Anti-Bacterial Agents; Chitosan; Cross-Linking Reagents; Drug Delivery Systems; Drug Resistance, Multiple, Bacterial; Gels; Iridoids; Isoniazid; Lung; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Rifampin	2018
Mucoadhesive guargum hydrogel inter-connected chitosan-g-polycaprolactone micelles for rifampicin delivery. Carbohydrate polymers, 2019, Feb-15, Volume: 206 Topics: Animals; Antibiotics, Antitubercular; Apoptosis; Cell Survival; Chitosan; Chlorocebus aethiops; Drug Carriers; Drug Liberation; Galactans; Humans; Hydrogels; Klebsiella pneumoniae; Mannans; Micelles; Plant Gums; Polyesters; Polymers; Rifampin; Staphylococcus aureus; Vero Cells	2019
Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis. AAPS PharmSciTech, 2019, Jan-09, Volume: 20, Issue:2 Topics: Alginates; Animals; Antibiotics, Antitubercular; Ascorbic Acid; Cell Survival; Chitosan; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Rifampin; Vero Cells	2019
Controlled release studies through chitosan-based hydrogel synthesized at different polymerization stages. International journal of biological macromolecules, 2019, May-01, Volume: 128 Topics: Chitosan; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; Polymerization; Rifampin; Temperature	2019
Embedment of liposomes into chitosan physical hydrogel for the delayed release of antibiotics or anaesthetics, and its first ESEM characterization. Carbohydrate polymers, 2020, Feb-01, Volume: 229 Topics: Anesthetics; Anti-Bacterial Agents; Chitosan; Drug Liberation; Fluoresceins; Hydrogels; Lidocaine; Liposomes; Microscopy, Electron, Scanning; Rheology; Rifampin	2020
Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route. Nanomedicine (London, England), 2020, Volume: 15, Issue:2 Topics: Administration, Topical; Animals; Antiprotozoal Agents; Chitosan; Disease Models, Animal; Drug Delivery Systems; Flow Cytometry; Humans; Leishmaniasis, Cutaneous; Macrophages; Mice; Nanogels; Nanoparticles; Polyethylene Glycols; Polyethyleneimine; Rats; Rifampin	2020
Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus. Drug delivery and translational research, 2020, Volume: 10, Issue:5 Topics: Alginates; Animals; Anti-Bacterial Agents; Chitosan; Lung; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Rats; Rifampin; Staphylococcus aureus	2020
Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages. Carbohydrate polymers, 2021, Jan-15, Volume: 252 Topics: A549 Cells; Antibiotics, Antitubercular; Chitosan; Drug Carriers; Drug Liberation; Humans; Lipids; Macrophages, Alveolar; Nanoparticles; Particle Size; Rifampin; Tuberculosis	2021
Self-crosslinked chitosan/dialdehyde xanthan gum blended hypromellose hydrogel for the controlled delivery of ampicillin, minocycline and rifampicin. International journal of biological macromolecules, 2021, Jan-15, Volume: 167 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Escherichia coli; Fibroblasts; Hydrogels; Hydrogen-Ion Concentration; Hypromellose Derivatives; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Minocycline; Polysaccharides, Bacterial; Rheology; Rifampin; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Thermogravimetry	2021
Exploring the Toxicity, Lung Distribution, and Cellular Uptake of Rifampicin and Ascorbic Acid-Loaded Alginate Nanoparticles as Therapeutic Treatment of Lung Intracellular Infections. Molecular pharmaceutics, 2021, 03-01, Volume: 18, Issue:3 Topics: A549 Cells; Alginates; Animals; Antioxidants; Ascorbic Acid; Biological Transport; Cell Line; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Humans; Lung; Lung Diseases; Macrophages, Alveolar; Male; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Respiratory Mucosa; Rifampin; Swine; Tissue Distribution	2021
Preparation of Curdlan sulphate - Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages. Carbohydrate polymers, 2021, Apr-15, Volume: 258 Topics: Animals; beta-Glucans; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Hydrogen-Ion Concentration; Inflammation; Kinetics; Macrophages; Mice; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Nanoparticles; Polyelectrolytes; Polymers; RAW 264.7 Cells; Rifampin	2021
Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis. Drug delivery and translational research, 2021, Volume: 11, Issue:4 Topics: Chitosan; Drug Carriers; Humans; Mannose; Nanoparticles; Particle Size; Rifampin; Tuberculosis, Osteoarticular	2021
3D printable self-healing hyaluronic acid/chitosan polycomplex hydrogels with drug release capability. International journal of biological macromolecules, 2021, Oct-01, Volume: 188 Topics: Adhesiveness; Animals; Cell Death; Chitosan; Diclofenac; Drug Liberation; Hyaluronic Acid; Hydrogels; Hydrogen-Ion Concentration; Hydrolysis; Injections; Mice; Polyelectrolytes; Printing, Three-Dimensional; Rheology; Rifampin; Spectroscopy, Fourier Transform Infrared; Static Electricity; Time Factors; Viscosity	2021
Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular tuberculosis. Journal of materials chemistry. B, 2021, 10-06, Volume: 9, Issue:38 Topics: Animals; Antitubercular Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Cell Survival; Chitosan; Disease Models, Animal; Drug Carriers; Drug Liberation; Femur; Glycerophosphates; Hydrogels; Isoniazid; Mice; Mycobacterium tuberculosis; Porosity; Prostheses and Implants; Rifampin; Tuberculosis, Osteoarticular	2021
Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis. Drug development and industrial pharmacy, 2021, Volume: 47, Issue:12 Topics: Alginates; Chitosan; Drug Carriers; Humans; Polyelectrolytes; Polymers; Rifampin; Tuberculosis	2021
Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2022, Volume: 180 Topics: Anti-Infective Agents; Chitosan; Cyclodextrins; Drug Carriers; Nanoparticles; Particle Size; Polymers; Rifampin	2022
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Biomolecules, 2023, 05-31, Volume: 13, Issue:6 Topics: Anti-Bacterial Agents; Chitosan; Humans; Liposomes; Mycobacterium abscessus; Polylysine; Polymers; Rifampin	2023